Home › Funds › Alpine Peaks Capital, LP › WST

Alpine Peaks Capital, LP position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Alpine Peaks Capital, LP reported holding 19,191 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q2 2026 13F filing — a position valued at US$6.9M, representing 8.07% of its reported portfolio and ranking #2 among its reported holdings. Alpine Peaks Capital, LP has disclosed WST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)19.19K sh
Reported value held$6.89M
Portfolio Weight8.07%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alpine Peaks Capital, LP's WST position evolved

Alpine Peaks Capital, LP first disclosed a stake in WST in Q3 2023 at 20,827 shares (US$7.8M). The position peaked in Q1 2024 at 20,827 shares, worth US$8.2M. Across 12 filings, Alpine Peaks Capital, LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 19,191 shares valued at US$6.9M — a reduction of -10,692 shares quarter over quarter.. Notable position changes include a 36% trim in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 20.83K $7.81M New
Q4 2023 20.83K $7.33M Hold
Q1 2024 20.83K $8.24M Hold
Q2 2024 20.83K $6.86M Hold
Q3 2024 23.50K $7.05M Add
Q4 2024 19.73K $6.46M Reduce
Q1 2025 21.23K $4.75M Add
Q2 2025 21.83K $4.78M Add
Q3 2025 26.83K $7.04M Add
Q4 2025 26.48K $7.29M Reduce
Q1 2026 29.88K $7.49M Add
Q2 2026 19.19K $6.89M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Alpine Peaks Capital, LP held WST?

Alpine Peaks Capital, LP has disclosed WST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Alpine Peaks Capital, LP's current position in WST?

As of Q2 2026, Alpine Peaks Capital, LP holds 19.19K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $6.89M, representing 8.07% of its reported portfolio and ranking #2.

Has Alpine Peaks Capital, LP been buying or selling WST?

In the latest 13F filing (Q2 2026), Alpine Peaks Capital, LP reduced its position in WST. The position peaked in Q1 2024 at 20.83K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.